RxSight, Inc. increased earnings guidance for the full year 2024. For the year, the company expected revenue of $132.0 million to $137.0 million, representing implied growth of 48% to 54% compared to 2023, up from prior guidance of $128.0 million to $135.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.47 USD | -1.76% | -4.38% | +45.01% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.01% | 2.28B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- RXST Stock
- News RxSight, Inc.
- RxSight, Inc. Increases Earnings Guidance for the Full Year 2024